相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis
Zahoor Ahmad et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. tuberculosis
Alix Pantel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis
Frederick A. Sirgel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
Fernanda Maruri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
Seidu Malik et al.
PLOS ONE (2012)
Activity of Carbapenems Combined with Clavulanate against Murine Tuberculosis
Nicolas Veziris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
Nicolas Veziris et al.
PLOS ONE (2011)
Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant Tuberculosis
Doh Hyung Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Bactericidal Potencies of New Regimens Are Not Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis
Koen Andries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Should Moxifloxacin Be Used for the Treatment of Extensively Drug-Resistant Tuberculosis? An Answer from a Murine Model
Julien Poissy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis
Murad Ibrahim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
New Drugs against Tuberculosis: Problems, Progress, and Evaluation of Agents in Clinical Development
Jossy van den Boogaard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in Vietnam
Duong Duy An et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
Nicolas Allou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB
K. Kliiman et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation
Burkhard Springer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Clinical response and outcome of infection with Salmonella enterica serotype typhi with decreased susceptibility to fluoroquinolones:: a United States FoodNet multicenter retrospective cohort study
John A. Crump et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007
N. Sarita Shah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis:: Evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy
Radha K. Shandil et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration
Nacer Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Weekly moxifloxacin and rifapentine is more active than the Denver regimen in murine tuberculosis
IM Rosenthal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Mycobacterium tuberculosis DNA gyrase:: Interaction with quinolones and correlation with antimycobacterial drug activity
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates
AFB Cheng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia:: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants
D Croisier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo
N Veziris et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Gatifloxacin and ethionamide as the foundation for therapy of tuberculosis
MH Cynamon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Fluoroquinolones, tuberculosis, and resistance
AS Ginsburg et al.
LANCET INFECTIOUS DISEASES (2003)
Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones
D Croisier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
The treatment of multidrug-resistant tuberculosis in Turkey
K Tahaoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
